These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 4415353

  • 1. Proteinuria-lowering effect of anti-inflammatory drugs.
    Pasero G, Corsini G, Palia R, Rindi P.
    Curr Med Res Opin; 1974; 2(5):270-4. PubMed ID: 4415353
    [No Abstract] [Full Text] [Related]

  • 2. Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.
    Vriesendorp R, de Zeeuw D, de Jong PE, Donker AJ, Pratt JJ, van der Hem GK.
    Clin Nephrol; 1986 Feb; 25(2):105-10. PubMed ID: 3516475
    [Abstract] [Full Text] [Related]

  • 3. [Isolated permanent proteinuria. 2. Developmental stability. 3. Nosologic significance].
    Antoine B, Symvouldis A, Dardenne M, De Montera H, Bach JF.
    Presse Med (1893); 1969 Jan 11; 77(2):51-3. PubMed ID: 4182077
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of nicotinic acid on the behavior of proteinuria in the nephrotic syndrome].
    Guarini G, Cicchetti E, Marino O, Russo P, Sellitti I, Silvestrini M.
    Minerva Med; 1982 Feb 18; 73(6):275-6. PubMed ID: 7058020
    [No Abstract] [Full Text] [Related]

  • 5. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
    Am J Kidney Dis; 2000 Mar 18; 35(3):381-91. PubMed ID: 10692263
    [Abstract] [Full Text] [Related]

  • 6. [Moderate doses of prednisone in the treatment of idiopathic membranous glomerulonephritis with nephrotic proteinuria].
    Klinger M, Szewczyk Z, Strychowski J, Tupka D.
    Przegl Lek; 1987 Mar 18; 44(7):529-33. PubMed ID: 3685441
    [No Abstract] [Full Text] [Related]

  • 7. Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
    Ishikawa H, Honjo A, Hayashi M, Hamaguchi T, Morita T, Shindo T, Tetsutani T, Yamamoto T, Okubo H, Oka G.
    Arzneimittelforschung; 1982 Mar 18; 32(3):301-9. PubMed ID: 7200790
    [No Abstract] [Full Text] [Related]

  • 8. The clinical features and prognosis of patients with normocomplementemic mesangiocapillary glomerulonephritis.
    Cameron JS, Ogg CS, White RH, Glasgow EF.
    Clin Nephrol; 1973 Mar 18; 1(1):8-13. PubMed ID: 4767355
    [No Abstract] [Full Text] [Related]

  • 9. Idiopathic membranous nephropathy.
    Pierides AM, Kerr DN.
    Nephron; 1978 Mar 18; 20(6):301-3. PubMed ID: 662048
    [No Abstract] [Full Text] [Related]

  • 10. The long-term course of poststreptococcal glomerulonephritis.
    Baldwin DS, Gluck MC, Schacht RG, Gallo G.
    Ann Intern Med; 1974 Mar 18; 80(3):342-58. PubMed ID: 4816174
    [No Abstract] [Full Text] [Related]

  • 11. Effects of nonsteroidal anti-inflammatory drugs on proteinuria.
    Vriesendorp R, Donker AJ, de Zeeuw D, de Jong PE, van der Hem GK, Brentjens JR.
    Am J Med; 1986 Aug 25; 81(2B):84-94. PubMed ID: 3529951
    [Abstract] [Full Text] [Related]

  • 12. Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study.
    Vriesendorp R, Donker AJ, de Zeeuw D, de Jong PE, van der Hem GK.
    Am J Nephrol; 1985 Aug 25; 5(4):236-42. PubMed ID: 3901756
    [Abstract] [Full Text] [Related]

  • 13. Proteinuria and hemoglobin levels in patients with primary glomerular disease.
    Mähr N, Neyer U, Prischl F, Kramar R, Mayer G, Kronenberg F, Lhotta K.
    Am J Kidney Dis; 2005 Sep 25; 46(3):424-31. PubMed ID: 16129203
    [Abstract] [Full Text] [Related]

  • 14. [Adult nephrotic syndrome].
    Maeda T.
    Naika; 1971 Jun 25; 27(6):1415-9. PubMed ID: 5092055
    [No Abstract] [Full Text] [Related]

  • 15. [Results of associated immunosuppressive -- antiphlogistic treatment of proliferative glomerulonephritis (author's transl)].
    Szewczyk Z, Szepietowski T, Falkiewicz K, Rabczyński J.
    Przegl Lek; 1976 Jun 25; 33(5):550-4. PubMed ID: 948642
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical and prognostic significance of histological classification in glomerulonephritis].
    Renner E, Edel H, Eigler J, Buchborn E.
    Klin Wochenschr; 1969 Jul 15; 47(14):752-9. PubMed ID: 5382556
    [No Abstract] [Full Text] [Related]

  • 17. Fetal Renal Stem Cell Transplant in Nephrotic and Nonnephrotic Glomerulonephritis with Stage 2-4 Chronic Kidney Disease: Potential Effect on Proteinuria and Glomerular Filtration Rate.
    Tuganbekova S, Gaipov A, Turebekov Z, Saparbayev S, Shaimardanova G, Popova N, Taubaldiyeva Z, Serebrennikova D, Trimova R.
    Exp Clin Transplant; 2015 Nov 15; 13 Suppl 3():156-9. PubMed ID: 26640940
    [Abstract] [Full Text] [Related]

  • 18. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G, Masbernard A, Giudicelli C, Hirbec G.
    Arzneimittelforschung; 1974 Sep 15; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract] [Full Text] [Related]

  • 19. Membranoproliferative glomerulonephritis and persistent hypocomplementaemia.
    Cameron JS, Glasgow EF, Ogg CS, White RH.
    Br Med J; 1970 Oct 03; 4(5726):7-14. PubMed ID: 4097129
    [Abstract] [Full Text] [Related]

  • 20. [Percutaneous therapy of soft tissue rheumatic diseases. Clinical trials of the non-steroid anti-phlogistic agent Rheumon gel].
    Podzich M.
    ZFA (Stuttgart); 1982 Jun 10; 58(16):921-4. PubMed ID: 7051600
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.